Bronchial gene expression alterations associated with radiological bronchiectasis.

"Conflict of interest: A.A. Diaz reports a provisional patent for genetic signatures to identify bronchiectasis filed in the United States Patent and Trademark Office (Patent of Novel Essays to Detect Respiratory Diseases and Disorders) outside the submitted work. M.H. Cho reports grants from GSK and Bayer; consulting fees from AstraZeneca and Genentech; lecture honoraria from Illumina; outside the submitted work. A.C. Gower reports grants from Novartis and Johnson & Johnson (JNJ) Immunology; outside the submitted work. A. Spira reports being a current employee of JNJ. D.R. Aberle reports grants from American College of Radiology, Boston University, NIH/NCI (R01 CA226079, U01 CA233370, R01 CA210360, U01 CA214182) and Kaiser Foundation Research Institute/PCORI (prime); travel support from American Institute for Medical and Biological Engineering (AIMBE), Cleveland Clinic, Specialized Programs of Research Excellence (SPOREs) Workshop and International Association for the Study of Lung Cancer (IASLC); outside the submitted work. G.R. Washko reports grants from NIH and DoD; consulting fees from Boehringer Ingelheim, CSL Behring, GlaxoSmithKline, Novartis, Philips and Vertex Pharmaceuticals; travel support from Philips; participation on advisory board with Pulmonx; outside the submitted work; is a co-founder and equity share holder in Quantitative Imaging Solutions, a company that provides consulting services for image and data analytics; and G.R. Washko's spouse works for Biogen. E. Billatos reports grants from NIH (1R01HL149861-01A1), Novartis Institutes of Biomedical Research and International Association for the Study of Lung Cancer; a patent application filed stemming from research described in this manuscript from Boston University; outside the submitted work. M.E. Lenburg reports Johnson and Johnson, Novartis Institute for Biomedical Research; consulting fees from Johnson and Johnson; a patent application filed stemming from research described in this manuscript from Boston University; outside the submitted work. All other authors have nothing to disclose."

"Support statement: The DECAMP study is supported by funds from the Department of Defense (W81XWH-11-2-0161), the National Cancer Institute (U01CA196408), and Johnson and Johnson Services, Inc (JJSI). Funding information for this article has been deposited with the Crossref Funder Registry."